
Aging Pathobiology and Therapeutics
Aging Pathobiology and Therapeutics (APT, Online ISSN 2690-1803) is an open access, peer-reviewed, interdisciplinary journal available online. The journal quarterly publishes research articles, reviews, editorials, case reports, opinions, letters, abstracts and drug therapeutic brief relating to research on Aging related diseases. The journal aims to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of Aging Pathobiology and Therapeutics research. Scholars from the disciplines of geriatrics, gerontology, physiology, pathology, pharmacology, toxicology, biology, neuropsychology, psychology, nursing, epidemiology, and genetics are encouraged to contribute articles to the journal.
Vol 4, No 1 (2022): Aging Pathobiology and Therapeutics has been published, welcome to read!
To provide young scholars with an active academic exchange platform for exchanging ideas with each other and with influential experts in aging and age-related diseases, and cultivate candidates for Aging Pathobiology and Therapeutics (APT), the Editorial Office plans to recruit junior Editorial Board members worldwide from now on.
We kindly invite you to submit a manuscript for publication in Aging Pathobiology and Therapeutics (APT). The academic articles in the journal will be published online, through Open Access mode, and will be available worldwide freely and immediately, without restrictions.
Aging Pathobiology and Therapeutics has added a special issue column, and now we sincerely invite Guest Editors to join us.